Adlai Nortye ANL
NASDAQ ANL
$15.01 +0.26 (+1.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Other Non-Current Assets (2022 - 2026)

Adlai Nortye (ANL) posted quarterly Other Non-Current Assets of $31.8 million for Q2 2024, up 28.17% quarter-over-quarter from $24.8 million in Q4 2023.

Analysis

Adlai Nortye (ANL) Other Non-Current Assets (2022 - 2026) Analysis & Trends

Adlai Nortye (ANL) has reported Other Non-Current Assets for 3 consecutive years, with $31.8 million the latest figure, recorded in Q2 2024.

  • In Q2 2024, Other Non-Current Assets changed N/A year-over-year to $31.8 million; the TTM figure through Jun 2024 stood at $31.8 million (changed N/A YoY), while the FY2023 annual figure was $24.8 million, up 7499.08% from the prior year.
  • Other Non-Current Assets improved to $31.8 million in Q2 2024 per ANL's latest filing, from $24.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $31.8 million in Q2 2024 and bottomed at $327000.0 in Q4 2022.
  • Historically, Other Non-Current Assets has averaged $19.0 million across 3 years, with a median of $24.8 million in 2023.
  • On a YoY basis, Other Non-Current Assets climbed as much as 7499.08% in 2023 and fell as far as 7499.08% in 2023.
  • Adlai Nortye's Other Non-Current Assets stood at $327000.0 in 2022, then surged by 7499.08% to $24.8 million in 2023, then advanced by 28.17% to $31.8 million in 2024.
  • Business Quant data shows ANL's Other Non-Current Assets at $31.8 million in Q2 2024, $24.8 million in Q4 2023, and $327000.0 in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Adlai Nortye 500.08 Mn 268.19 Mn - 80,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80,000.00
Dec 31, 2025 15.73 Mn
Jun 30, 2025 18.24 Mn
Dec 31, 2023 252.81 Mn
Dec 31, 2022 210.04 Mn